312
Participants
Start Date
September 26, 2024
Primary Completion Date
July 1, 2027
Study Completion Date
September 1, 2027
Standard Dose Quadrivalent Inactivated Influenza Vaccine
Fluzone ® Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by two influenza A subtype viruses and two type B viruses contained in the vaccine.
High Dose Quadrivalent Inactivated Influenza Vaccine
"Fluzone High-Dose (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is concentrated and purified in a linear sucrose density gradient solution using a continuous flow centrifuge. The virus is then chemically disrupted using a non-ionic surfactant, octylphenol ethoxylate (Triton® X-100), producing a split virus. The split virus is further purified and then suspended in sodium phosphatebuffered isotonic sodium chloride solution. The Fluzone High-Dose process uses an additional concentration factor after the ultrafiltration step in order to obtain a higher hemagglutinin (HA) antigen concentration."
RECRUITING
UPMC Children's Hospital of Pittsburgh, Pittsburgh
RECRUITING
Children's Healthcare of Atlanta, Atlanta
RECRUITING
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
Ann Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
Children's Mercy Hospital, Kansas City
RECRUITING
Texas Children's Hospital, Houston
RECRUITING
Stanford University, Stanford
National Institute of Allergy and Infectious Diseases (NIAID)
NIH